StockData

Seaport Therapeutics, Inc. (SPTX) stock

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

Seaport Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Seaport Therapeutics's enterprise value was $867.43M on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$867.43M–

More Seaport Therapeutics figures

See a number that looks wrong?